Liver Metastases From Breast Cancer: What Role for Surgery? Indications and Results

[1]  G. Spolverato,et al.  Liver Resection for Breast Cancer Liver Metastases: A Cost-utility Analysis , 2017, Annals of surgery.

[2]  I. Gibbs,et al.  Cost-Effectiveness of Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  B. Asselain,et al.  Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  Bing-he Xu,et al.  Better pathologic complete response and relapse-free survival after carboplatin plus paclitaxel compared with epirubicin plus paclitaxel as neoadjuvant chemotherapy for locally advanced triple-negative breast cancer: a randomized phase 2 trial , 2016, Oncotarget.

[5]  C. Hudis,et al.  Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients , 2016, Annals of surgery.

[6]  B. Kang,et al.  Extramammary findings on breast MRI: prevalence and imaging characteristics favoring malignancy detection: a retrospective analysis , 2016, World Journal of Surgical Oncology.

[7]  Jeffrey E. Lee,et al.  Advances in hepatectomy technique: Toward zero transfusions in the modern era of liver surgery. , 2016, Surgery.

[8]  J. Samra,et al.  Resection of colorectal liver metastases and extra-hepatic disease: a systematic review and proportional meta-analysis of survival outcomes. , 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[9]  E. Vibert,et al.  Evidence of intermetastatic heterogeneity for pathological response and genetic mutations within colorectal liver metastases following preoperative chemotherapy , 2016, Oncotarget.

[10]  H. Miyata,et al.  Changes in tumor expression of HER2 and hormone receptors status after neoadjuvant chemotherapy in 21,755 patients from the Japanese breast cancer registry. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  T. Baère,et al.  Percutaneous Thermal Ablation of Breast Cancer Metastases in Oligometastatic Patients , 2016, CardioVascular and Interventional Radiology.

[12]  D. Pezet,et al.  High Resectability Rate of Initially Unresectable Colorectal Liver Metastases After UGT1A1-Adapted High-Dose Irinotecan Combined with LV5FU2 and Cetuximab: A Multicenter Phase II Study (ERBIFORT) , 2016, Annals of Surgical Oncology.

[13]  Gary J Whitman,et al.  Prognosis for patients with metastatic breast cancer who achieve a no‐evidence‐of‐disease status after systemic or local therapy , 2015, Cancer.

[14]  S. Giacchetti,et al.  Repeat Hepatectomy for Breast Cancer Liver Metastases , 2015, Annals of Surgical Oncology.

[15]  M. Büchler,et al.  Is Hepatic Resection for Non-colorectal, Non-neuroendocrine Liver Metastases Justified? , 2015, Annals of Surgical Oncology.

[16]  S. Saab,et al.  Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors. , 2015, World journal of gastroenterology.

[17]  Carsten Denkert,et al.  Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial. , 2015, JAMA oncology.

[18]  Brice Gayet,et al.  Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. , 2015, Annals of surgery.

[19]  T. Sohda,et al.  Why is radiofrequency ablation therapy applied for hepatocellular carcinoma up to 3 nodules and smaller than 3 cm in tumor size? , 2014, Hepato-Gastroenterology.

[20]  W. Gradishar,et al.  Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy. , 2014, Journal of vascular and interventional radiology : JVIR.

[21]  H. Kuerer,et al.  Residual tumor thickness at the tumor-normal tissue interface predicts the recurrence-free survival in patients with liver metastasis of breast cancer. , 2014, Annals of diagnostic pathology.

[22]  X. Pivot,et al.  A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: an analysis of the ATHENA trial. , 2014, Breast.

[23]  V. Herlea,et al.  Role of surgical treatment in breast cancer liver metastases: a single center experience. , 2014, Anticancer research.

[24]  M. Piccart,et al.  ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)† , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  H. Rugo,et al.  Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER , 2014, British Journal of Cancer.

[26]  Jinha M. Park,et al.  Complete pathologic response of HER2-positive breast cancer liver metastasis with dual Anti-HER2 antagonism , 2014, BMC Cancer.

[27]  Seung Ah Lee,et al.  Does Liver Resection Provide Long-Term Survival Benefits for Breast Cancer Patients with Liver Metastasis? A Single Hospital Experience , 2014, Yonsei medical journal.

[28]  B. Rau,et al.  Liver Resections of Isolated Liver Metastasis in Breast Cancer: Results and Possible Prognostic Factors , 2014, HPB surgery : a world journal of hepatic, pancreatic and biliary surgery.

[29]  H. Seo,et al.  Comparative analysis of radiofrequency ablation and resection for resectable colorectal liver metastases. , 2014, World journal of gastroenterology.

[30]  V. Servois,et al.  Liver metastases from breast cancer: Surgical resection or not? A case-matched control study in highly selected patients. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[31]  E. Berber,et al.  A comparison of laparoscopic radiofrequency ablation versus systemic therapy alone in the treatment of breast cancer metastasis to the liver. , 2013, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[32]  M. Ychou,et al.  A Randomized Phase II Trial of Three Intensified Chemotherapy Regimens in First-Line Treatment of Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases. The METHEP Trial , 2013, Annals of Surgical Oncology.

[33]  D. Kostov,et al.  Prognostic Factors Related to Surgical Outcome of Liver Metastases of Breast Cancer , 2013, Journal of breast cancer.

[34]  O. Dirsch,et al.  Liver resection in selected patients with metastatic breast cancer: a single-centre analysis and review of literature , 2013, Journal of Cancer Research and Clinical Oncology.

[35]  S. Zangos,et al.  Thermal ablation therapies in patients with breast cancer liver metastases: A review , 2013, European Radiology.

[36]  Ti Zhang,et al.  The prognostic analysis of clinical breast cancer subtypes among patients with liver metastases from breast cancer , 2013, International Journal of Clinical Oncology.

[37]  E. Van Cutsem,et al.  The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. , 2012, The oncologist.

[38]  R. van Hillegersberg,et al.  Resection of liver metastases in patients with breast cancer: survival and prognostic factors. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[39]  M. Kanematsu,et al.  Diffusion/perfusion MR imaging of the liver: practice, challenges, and future. , 2012, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[40]  P. Bachellier,et al.  Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. , 2012, Annals of surgery.

[41]  H. Lee,et al.  Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer , 2012, BMC Cancer.

[42]  H. Kuerer,et al.  Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome. , 2012, Surgery.

[43]  T. Chua,et al.  Hepatic resection for metastatic breast cancer: a systematic review. , 2011, European journal of cancer.

[44]  M. Ernst,et al.  The role of surgery in metastatic breast cancer. , 2011, European journal of cancer.

[45]  B. Skjoldbye,et al.  Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients. , 2011, Ultraschall in der Medizin.

[46]  E. Winer,et al.  International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured? , 2010, Journal of the National Cancer Institute.

[47]  J. Ferlay,et al.  Estimates of cancer incidence and mortality in Europe in 2008. , 2010, European journal of cancer.

[48]  R. J. Haas,et al.  Liver resection of colorectal metastases in elderly patients , 2010, The British journal of surgery.

[49]  T. Livraghi,et al.  Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates. , 2009, Radiology.

[50]  A. Yosepovich,et al.  Hormone Receptor Expression Is Associated With a Unique Pattern of Metastatic Spread and Increased Survival Among HER2-Overexpressing Breast Cancer Patients , 2009, American journal of clinical oncology.

[51]  R. Adam,et al.  R1 Resection by Necessity for Colorectal Liver Metastases: Is It Still a Contraindication to Surgery? , 2008, Annals of surgery.

[52]  M. Scotté,et al.  Liver resection for breast cancer metastasis: Does it improve survival? , 2008, Surgery Today.

[53]  C. Rimkus,et al.  [Is liver resection justified for patients with hepatic metastases from breast cancer?]. , 2007, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

[54]  Monica Morrow,et al.  Local therapy and survival in breast cancer. , 2007, The New England journal of medicine.

[55]  E. Winer,et al.  Metastatic breast cancer. Recommendations proposal from the European School of Oncology (ESO)-MBC Task Force. , 2007, Breast.

[56]  D. Jaeck,et al.  Hepatic Resection for Noncolorectal Nonendocrine Liver Metastases: Analysis of 1452 Patients and Development of a Prognostic Model , 2006, Annals of surgery.

[57]  A. Giuliano,et al.  The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases. , 2006, American journal of surgery.

[58]  T. Helmberger,et al.  Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors. , 2005, Cancer biotherapy & radiopharmaceuticals.

[59]  M. Makuuchi,et al.  Hepatic Resection for Metastatic Breast Cancer: Prognostic Analysis of 34 Patients , 2005, World Journal of Surgery.

[60]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[61]  Armando Santoro,et al.  Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. , 2004, The New England journal of medicine.

[62]  Ping Liang,et al.  Prognostic factors for percutaneous microwave coagulation therapy of hepatic metastases. , 2003, AJR. American journal of roentgenology.

[63]  G. Hortobagyi,et al.  A role for curative surgery in the treatment of selected patients with metastatic breast cancer. , 2003, The oncologist.

[64]  M. Druet‐Cabanac,et al.  An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. , 2003, American journal of surgery.

[65]  G. Gazelle,et al.  Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients. , 2001, Radiology.

[66]  R. Salmon,et al.  Résections hépatiques pour métastases de cancer du sein : résultats et facteurs pronostiques (65 cas) , 2001 .

[67]  W. Meyers,et al.  Liver metastases from breast cancer: long-term survival after curative resection. , 2000, Surgery.

[68]  B. Asselain,et al.  Hepatic resection in metastatic breast cancer: results and prognostic factors. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[69]  A. Seidman,et al.  Chemotherapy for advanced breast cancer: a current perspective. , 1996, Seminars in oncology.

[70]  L. Callans,et al.  Recurrent breast cancer: presentation, diagnosis, and treatment. , 1993, Seminars in oncology.

[71]  J. Hainsworth,et al.  Metastatic breast cancer confined to the skeletal system: An indolent disease☆ , 1986 .

[72]  A. Darzi,et al.  Recommendations for laparoscopic liver resection : a report from the second international consensus conference held in , 2017 .

[73]  C. la Vecchia,et al.  Trastuzumab for HER2+ metastatic breast cancer in clinical practice: Cardiotoxicity and overall survival. , 2016, European journal of cancer.

[74]  G. Lopes,et al.  A cost effectiveness study of eribulin versus standard single-agent cytotoxic chemotherapy for women with previously treated metastatic breast cancer , 2012, Breast Cancer Research and Treatment.

[75]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[76]  L. Fallowfield,et al.  Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[77]  U. Neumann,et al.  Liver resection for metastases from breast cancer , 2008, Journal of surgical oncology.

[78]  L. Ellis,et al.  Long-term Survival After An Aggressive Surgical Approach in Patients With Breast Cancer Hepatic Metastases , 2004, Annals of Surgical Oncology.

[79]  B. Asselain,et al.  [Hepatic resection for breast cancer metastases: results and prognosis (65 cases)]. , 2001, Annales de chirurgie.